Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Hebert

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|November 26, 2016
Anticoagulant-Related Nephropathy: Is an AKI Elephant Hiding in Plain View?Sergey V Brodsky, Lee A Hebert
Annals of Internal Medicine|January 6, 2010
Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitisLee A Hebert, Brad H Rovin
The New England Journal of Medicine|January 22, 2015
Rituximab or azathioprine maintenance in ANCA-associated vasculitisLee A Hebert, Anthony Alvarado, Brad Rovin
Journal of the American Society of Nephrology : JASN|November 14, 2018
Anticoagulant-Related NephropathySergey Brodsky, John Eikelboom, Lee A Hebert
The New England Journal of Medicine|November 19, 2010
Rituximab or cyclophosphamide in ANCA-associated renal vasculitisLee A Hebert, Stacy Ardoin, Rosemarie L Shim
The New England Journal of Medicine|September 9, 2006
Measured and estimated glomerular filtration rateLee A Hebert, Uday Nori, Paul L Hebert
Current Hypertension Reports|September 15, 2005
Should the target for blood pressure control specify both a systolic and a diastolic component?Christopher J Hebert, Ganesh Shidham, Lee A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2010
Measured GFR has limited clinical utilityUday S Nori, Todd E Pesavento, Lee A Hebert
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2011
Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamideSergey V Brodsky, Brad H Rovin, Lee A Hebert
Nature Clinical Practice. Nephrology|January 26, 2007
The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohortLee A Hebert, Brad H Rovin, Christopher J Hebert
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|November 26, 2016
Anticoagulant-Related Nephropathy: Is an AKI Elephant Hiding in Plain View?Sergey V Brodsky, Lee A Hebert
Annals of Internal Medicine|January 6, 2010
Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitisLee A Hebert, Brad H Rovin
The New England Journal of Medicine|January 22, 2015
Rituximab or azathioprine maintenance in ANCA-associated vasculitisLee A Hebert, Anthony Alvarado, Brad Rovin
Journal of the American Society of Nephrology : JASN|November 14, 2018
Anticoagulant-Related NephropathySergey Brodsky, John Eikelboom, Lee A Hebert
The New England Journal of Medicine|November 19, 2010
Rituximab or cyclophosphamide in ANCA-associated renal vasculitisLee A Hebert, Stacy Ardoin, Rosemarie L Shim
The New England Journal of Medicine|September 9, 2006
Measured and estimated glomerular filtration rateLee A Hebert, Uday Nori, Paul L Hebert
Current Hypertension Reports|September 15, 2005
Should the target for blood pressure control specify both a systolic and a diastolic component?Christopher J Hebert, Ganesh Shidham, Lee A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2010
Measured GFR has limited clinical utilityUday S Nori, Todd E Pesavento, Lee A Hebert
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2011
Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamideSergey V Brodsky, Brad H Rovin, Lee A Hebert
Nature Clinical Practice. Nephrology|January 26, 2007
The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohortLee A Hebert, Brad H Rovin, Christopher J Hebert
Pageof 8